
Moderna's coronavirus vaccine on Friday became the second to receive emergency use authorization from the U.S. Food and Drug Administration (FDA), providing some welcome news to a country with a staggering COVID-19 death toll of over 312,000.
from CBC | Health News https://ift.tt/3h31iqZ
Aucun commentaire:
Enregistrer un commentaire